- Title
- Palliative Radiotherapy Given Concurrently or Within 4 Weeks of Initiation of Immunotherapy is Associated with Sustained Clinical Response to Immune Checkpoint Inhibitors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Creators
- R.M. Whitaker - Vanderbilt University Medical CenterE.A. Gillaspie - Vanderbilt University Medical CenterL. Horn - Vanderbilt University Medical CenterE.C. Osmundson - Vanderbilt University Medical Center
- Publication Details
- International journal of radiation oncology, biology, physics, Vol.105(1), pp.E538-E538
- Publisher
- Elsevier Inc
- Identifiers
- 991006161429402656
- Academic Unit
- Surgery
- Language
- English
- Resource Type
- Journal article
Journal article
Palliative Radiotherapy Given Concurrently or Within 4 Weeks of Initiation of Immunotherapy is Associated with Sustained Clinical Response to Immune Checkpoint Inhibitors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
International journal of radiation oncology, biology, physics, Vol.105(1), pp.E538-E538
09/01/2019
Metrics
1 Record Views